Valuation: Becton, Dickinson and Company

Market Cap 48.76B 43.36B 40.52B 36.95B 69.35B 4,696B 70.37B 490B 190B 2,394B 183B 179B 7,704B P/E 2026 *
34.3x
P/E 2027 * 19.1x
Enterprise Value 64.64B 57.49B 53.72B 48.98B 91.94B 6,226B 93.3B 649B 252B 3,174B 243B 237B 10,214B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.18x
Free-Float
73.18%
Yield 2026 *
2.2%
Yield 2027 * 2.24%
1 day-1.44%
1 week-2.08%
Current month-0.55%
1 month-4.69%
3 months+17.91%
6 months+14.51%
Current year-8.44%
1 week 177.28
Extreme 177.28
187.5
1 month 174.85
Extreme 174.85
193
Current year 139.58
Extreme 139.58
212.51
1 year 139.58
Extreme 139.58
212.51
3 years 139.58
Extreme 139.58
269.21
5 years 139.58
Extreme 139.58
286.33
10 years 139.58
Extreme 139.58
286.33
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer 56 2023-12-03
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-2.08% - - 48.76B
-2.17%-6.57%-27.81%-0.17% 171B
+0.17%-3.20%-9.24%+10.31% 110B
-0.88%-0.16%-26.16%-0.11% 106B
-0.69%-3.57%-47.61%-12.45% 75.99B
+3.17%-0.80%-0.88%+72.13% 57.3B
-0.52%-2.44%-4.86%-31.12% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.85%-0.82%-18.96%+18.41% 41.14B
-0.07%-1.71%+28.15%-7.58% 32.56B
Average +0.38%-1.46%-9.81%+12.06% 77B
Weighted average by Cap. +0.44%-2.07%-16.38%+9.01%

Financials

2026 *2027 *
Net sales 19.28B 17.14B 16.02B 14.61B 27.42B 1,857B 27.82B 194B 75.02B 946B 72.37B 70.8B 3,046B 19.73B 17.55B 16.4B 14.95B 28.07B 1,900B 28.48B 198B 76.79B 969B 74.08B 72.47B 3,118B
Net income 1.44B 1.28B 1.19B 1.09B 2.04B 138B 2.07B 14.43B 5.59B 70.53B 5.39B 5.28B 227B 2.34B 2.08B 1.94B 1.77B 3.33B 225B 3.38B 23.5B 9.1B 115B 8.78B 8.59B 370B
Net Debt 15.88B 14.13B 13.2B 12.04B 22.59B 1,530B 22.93B 160B 61.82B 780B 59.64B 58.34B 2,510B 13.95B 12.41B 11.59B 10.57B 19.84B 1,344B 20.14B 140B 54.29B 685B 52.38B 51.24B 2,204B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-10-01 US$177.45 -1.47% 654
26-09-30 US$180.10 -0.88% 89
26-09-29 US$181.69 -0.98% 100
26-09-28 US$183.48 +0.27% 866
26-09-25 US$182.98 +1.63% 97
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
178.07USD
Average target price
195.67USD
Spread / Average Target
+9.88%

Quarterly revenue - Rate of surprise